Cargando…
Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
BACKGROUND: An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy or risks associated with PAC, guidelines are empiric or su...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482554/ https://www.ncbi.nlm.nih.gov/pubmed/31023275 http://dx.doi.org/10.1186/s12882-019-1336-8 |